z-logo
open-access-imgOpen Access
Hypothesis: Bradykinin Blockers Might Reduce the Need for Ventilators for COVID-19 Patients
Author(s) -
Olusayo Louise Oluwasanmi
Publication year - 2020
Publication title -
journal of advances in medicine and medical research
Language(s) - English
Resource type - Journals
ISSN - 2456-8899
DOI - 10.9734/jammr/2020/v32i1230537
Subject(s) - bradykinin , covid-19 , medicine , case fatality rate , pulmonary edema , intensive care medicine , anesthesia , lung , virology , infectious disease (medical specialty) , receptor , disease , epidemiology , outbreak
The symptoms of COVID-19, leading to pulmonary edema and the need for ventilators may be due to the fact that the virus increases bradykinin levels. If true, administering bradykinin blockers can provide a cheap way to reduce the severity of the symptoms and the burden on hospital resources, and, ultimately, the fatality rate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here